The Wolverine Protocol combines TB500 and BPC-157 to accelerate connective tissue remodeling and reinforce structural strength. Built for tendons, ligaments, and load-bearing tissue under stress, it drives collagen adaptation and mechanical resilience during performance rebuilding phases.

Supplied as a 10 mg pre-reconstituted cartridge for use in The Clinic pen system (200 clicks).

Composition

Each cartridge contains:

• TB500 – 5 mg
• BPC-157 – 5 mg

Total: 10 mg per 2 mL cartridge
200 clicks per pen

This dual-peptide formulation is designed specifically for structural regeneration and connective tissue reinforcement.

Mechanism of Action

TB500 – Systemic Repair Signaling

TB500 enhances cellular migration and tissue remodeling while supporting angiogenesis. It improves the systemic repair environment and accelerates connective tissue recovery efficiency.

• Enhanced tissue remodeling signaling
• Improved vascular support
• Increased repair communication across muscle and connective tissue

BPC-157 – Targeted Structural Repair

BPC-157 reinforces tendon-to-bone integrity and supports localized connective tissue healing under strain.

• Tendon and ligament repair support
• Improved structural integrity in load-bearing tissue
• Enhanced resilience under mechanical stress

Together, these peptides drive forward structural adaptation.

Regenerative Focus

Wolverine is designed for:

• Collagen remodeling acceleration
• Connective tissue strengthening
• Tendon and ligament density adaptation
• Mechanical load tolerance development

This is a structural reinforcement protocol. It is best deployed when inflammation is controlled and tissue stability is established.

Ideal Use Cases

• Connective tissue strengthening phases
• Tendon and ligament resilience development
• Return-to-load training blocks
• Performance rebuilding cycles
• Structural reinforcement after early rehabilitation

Wolverine is appropriate when:

• Inflammation is minimal
• Tissue integrity is stable
• Mechanical output is increasing
• The objective is durability and strength

Dosage Protocol (Pen System)

• Total strength: 10 mg per cartridge
• Pen system: 2 mL / 200 clicks
• Strength per click: 0.05 mg per click

Click Conversion

Standard Structural Phase

20–40 clicks (1–2 mg)
5 times per week
Run 4–6 weeks

Advanced Structural Phase

40–80 clicks (2–4 mg)
5 times per week
Run 4–6 weeks

Administration: Subcutaneous. Rotate injection sites.

Cycle Structure

• Standard block: 4–6 weeks on / 2 weeks off
• Extended structural block: 6–8 weeks on / 4 weeks off

Designed for defined structural reinforcement phases rather than continuous use.

Expected Outcomes

Weeks 1–2

• Improved tissue responsiveness
• Reduced structural sensitivity under load

Weeks 3–6

• Increased connective tissue resilience
• Improved tendon density perception
• Greater mechanical load tolerance
• More confident return to heavy training

Position Within The Clinic System

Wolverine is typically deployed after Deadpool during phased regeneration, in performance rebuilding cycles, and during high-output training blocks.

Deadpool stabilizes the terrain. Wolverine reinforces the structure.